Korekiyo Wakitani

1.3k total citations
31 papers, 1.1k citations indexed

About

Korekiyo Wakitani is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Korekiyo Wakitani has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Pharmacology and 7 papers in Physiology. Recurrent topics in Korekiyo Wakitani's work include Inflammatory mediators and NSAID effects (8 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Korekiyo Wakitani is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Korekiyo Wakitani collaborates with scholars based in Japan and United States. Korekiyo Wakitani's co-authors include Fumihiko Yonemori, Hisashi Shinkai, Hiroshi Okamoto, Kimiya Maeda, Takashi Minowa, Jun‐ichi Haruta, Hiromasa Hashimoto, Kenichi Matsui, Satomi Takeuchi and Kochi Kakimoto and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Korekiyo Wakitani

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Korekiyo Wakitani Japan 17 458 339 331 194 176 31 1.1k
Dac M. Dinh United States 17 370 0.8× 344 1.0× 489 1.5× 144 0.7× 125 0.7× 29 1.1k
T. Saeki Japan 19 261 0.6× 238 0.7× 450 1.4× 214 1.1× 94 0.5× 60 1.0k
Susan Butler United States 9 704 1.5× 246 0.7× 653 2.0× 211 1.1× 96 0.5× 16 2.7k
Sampath Parthasarathy United States 10 267 0.6× 207 0.6× 257 0.8× 126 0.6× 87 0.5× 12 1.1k
Arnold D. Essenburg United States 20 692 1.5× 372 1.1× 679 2.1× 142 0.7× 78 0.4× 34 1.6k
Makoto Kakutani Japan 17 317 0.7× 218 0.6× 247 0.7× 47 0.2× 116 0.7× 35 1.2k
Terrance D. Barrett United States 17 403 0.9× 772 2.3× 557 1.7× 97 0.5× 207 1.2× 43 1.6k
Isabelle Escargueil‐Blanc France 16 282 0.6× 128 0.4× 593 1.8× 84 0.4× 57 0.3× 17 1.2k
Lubing Zhou United States 16 160 0.3× 173 0.5× 555 1.7× 71 0.4× 83 0.5× 33 1.0k
Reeba K. Vikramadithyan United States 18 146 0.3× 218 0.6× 654 2.0× 141 0.7× 95 0.5× 27 1.2k

Countries citing papers authored by Korekiyo Wakitani

Since Specialization
Citations

This map shows the geographic impact of Korekiyo Wakitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Korekiyo Wakitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Korekiyo Wakitani more than expected).

Fields of papers citing papers by Korekiyo Wakitani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Korekiyo Wakitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Korekiyo Wakitani. The network helps show where Korekiyo Wakitani may publish in the future.

Co-authorship network of co-authors of Korekiyo Wakitani

This figure shows the co-authorship network connecting the top 25 collaborators of Korekiyo Wakitani. A scholar is included among the top collaborators of Korekiyo Wakitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Korekiyo Wakitani. Korekiyo Wakitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyagawa, Naoki, et al.. (2008). Induction of late airway response was involved in serum antigen-specific immunoglobulin G in rats. International Immunopharmacology. 8(13-14). 1848–1853. 8 indexed citations
2.
Ueda, Yoshifumi, Naoki Miyagawa, & Korekiyo Wakitani. (2006). Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice. Life Sciences. 80(5). 414–419. 19 indexed citations
3.
IWAMURA, H., Motohide Sato, & Korekiyo Wakitani. (2004). Comparative Study of Glucocorticoids, Cyclosporine A, and JTE-607 [(-)-Ethyl-N-{3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzoyl}-l-phenylalaninate Dihydrochloride] in a Mouse Septic Shock Model. Journal of Pharmacology and Experimental Therapeutics. 311(3). 1256–1263. 16 indexed citations
4.
Cho, Hidetsura, Kazuhide Hayakawa, Yasunori Hase, et al.. (2003). Synthesis and Structure−Activity Relationships of 5,6,7,8-Tetrahydro-4H-thieno[3,2-b]azepine Derivatives:  Novel Arginine Vasopressin Antagonists. Journal of Medicinal Chemistry. 47(1). 101–109. 22 indexed citations
5.
Okamoto, Hiroshi, et al.. (2003). Effect of JTT-705 on cholesteryl ester transfer protein and plasma lipid levels in normolipidemic animals. European Journal of Pharmacology. 466(1-2). 147–154. 25 indexed citations
6.
Hashimoto, Hiromasa, et al.. (2002). 4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(1). 65–68. 12 indexed citations
7.
Okamoto, Hiroshi, Fumihiko Yonemori, Korekiyo Wakitani, et al.. (2000). A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature. 406(6792). 203–207. 426 indexed citations
8.
Takeuchi, Satomi, et al.. (2000). Effects of peroxisome proliferator‐activated receptor‐α and ‐γ agonist, JTT‐501, on diabetic complications in Zucker diabetic fatty rats. British Journal of Pharmacology. 130(3). 495–504. 77 indexed citations
9.
Furukawa, Noboru, et al.. (1999). Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound. European Journal of Pharmacology. 371(1). 51–58. 6 indexed citations
10.
Ohta, Takeshi, Noboru Furukawa, Fumihiko Yonemori, & Korekiyo Wakitani. (1999). JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats. European Journal of Pharmacology. 367(1). 91–99. 16 indexed citations
11.
Matsui, Kenichi, et al.. (1999). Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative. European Journal of Pharmacology. 364(2-3). 211–219. 50 indexed citations
12.
Ohta, Takeshi, et al.. (1999). JTT‐608 restores impaired early insulin secretion in diabetic Goto‐Kakizaki rats. British Journal of Pharmacology. 126(7). 1674–1680. 18 indexed citations
13.
Matsui, Kenichi, et al.. (1998). JTT‐501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non‐genetic insulin‐resistant models. British Journal of Pharmacology. 125(8). 1744–1750. 16 indexed citations
14.
Wakitani, Korekiyo, et al.. (1998). Profile of JTE-522 as a Human Cyclooxygenase-2 Inhibitor. The Japanese Journal of Pharmacology. 78(3). 365–372. 47 indexed citations
15.
16.
Fujitani, Buichi & Korekiyo Wakitani. (1990). Studies on antiplatelet effect of OP-41483, a prostaglandin I2 analog, in experimental animals. 1. Effect on platelet function and thrombosis.. The Japanese Journal of Pharmacology. 52(1). 123–130. 14 indexed citations
17.
Kondo, Kigen, et al.. (1989). Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis. European Journal of Pharmacology. 163(2-3). 253–261. 18 indexed citations
18.
Wakitani, Korekiyo, et al.. (1989). Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on blood vessels. European Journal of Pharmacology. 168(2). 193–200. 7 indexed citations
19.
Iguchi, Sadahiko, et al.. (1988). Effect of a prostacyclin analog OP-2507 on acute ischemic cerebral edema in cats. European Journal of Pharmacology. 152(1-2). 63–70. 13 indexed citations
20.
Wakitani, Korekiyo, et al.. (1986). Pharmacological Studies on the TXA2 Synthetase Inhibitor (E)-3-[p(1H-lmidazol-1-Ylmethyl)Phenyl]-2-Propenoic Acid (OKY-046). The Japanese Journal of Pharmacology. 41(3). 393–401. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dac M. Dinh Breakdown of academic impact, for papers by T. Saeki Breakdown of academic impact, for papers by Susan Butler Breakdown of academic impact, for papers by Sampath Parthasarathy Breakdown of academic impact, for papers by Arnold D. Essenburg Breakdown of academic impact, for papers by Makoto Kakutani Breakdown of academic impact, for papers by Terrance D. Barrett Breakdown of academic impact, for papers by Isabelle Escargueil‐Blanc Breakdown of academic impact, for papers by Lubing Zhou Breakdown of academic impact, for papers by Reeba K. Vikramadithyan
Rankless by CCL
2026